Not Yet RecruitingNot Applicable

Caudal Dexmedetomidine vs Ketamine for Postoperative Analgesia in Pediatric DDH Surgery

Egypt54 participantsStarted 2026-03-01

Plain-language summary

This study compares two medicines, Dexmedetomidine and Ketamine, added to caudal Bupivacaine to control pain after hip surgery in children. We will check how well each medicine reduces pain, how long the pain relief lasts, and if children need extra pain medicine. The goal is to find the safest and most effective option for postoperative pain relief in children undergoing hip surgery.

Who can participate

Age range1 Year – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 1 to 6 years undergoing surgery for developmental dysplasia of the hip * ASA physical status I or II * Parental or guardian informed consent obtained Exclusion Criteria: * Known allergy to local anesthetics, Dexmedetomidine, or Ketamine * Coagulopathy or bleeding disorders * Infection at the site of caudal injection * Neurological disorders * Severe systemic disease * Refusal of parental consent

What they're measuring

Postoperative Pain Score (FLACC)

Timeframe: First 24 hours post-surgery

Trial details

NCT IDNCT07385352

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

Contact for this trial

Abdelmon

+201116251563 Esraa.17289861@med.aun.edu.eg

View on ClinicalTrials.gov More Developmental Dysplasia of the Hip trials